{"name":"Shin Nippon Biomedical Laboratories, Ltd.","slug":"shin-nippon-biomedical-laboratories-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxQYjZHTWxoSXBZVUZTMHZtOF9ZT0NrbWd2U1RlMlo1ZUw5UHRxMU13N3FyVmUyenRseDJKa2g0eDJLVk55MUZCY25rTnh0Rjl1SDNzdklsVnRTdmNnNW52NE50VGQtM3VsUFZzWTYxemltWGhzaUlVWGVCNXhpWVdLWjZJNjFBT0s2TklPSEFsT2wyS2ltamtvcjA1T0h6UGs1eldLNVZGR3RNX0xPM1JxWkd2aHV4cFJMVldqazV0TVpZRmV0NzFuU0pzTnJiV2pQLWIxMDdETXNKM0RabGFsRHllNFJEeTFRcFNqWUI0cUw5Z3RJTWlrOG4wRXROQjl6VFM3NVo2LVd2T1N5MmJTZjNnQThESGtRV1p1SFVhUENtSlEzUDBJZWlJQ1FnVUMzWTVr?oc=5","date":"2025-11-05","type":"pipeline","source":"PR Newswire","summary":"Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache - PR Newswire","headline":"Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotami","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPVVNxSW0yTHhTREM4bWV4UkFVaDNZUnpNSl9tbXp4ckc4X1B5VXEzc0M0QzE5MWNxcHBmc0EtV0tQVktQeE9GV19fUVI5QkVQcElMNkhVeDBrR19fckVEVTlhS0F6X3VycnlJMDVCbVpwcmFTOFVSQmkxRi14ZUVEN0VaZXkxUThUdmcteTRfX2ppU3UxdXYwelIwSld1MU4xWFVsZ080b3pNZzBqajRTT254bTNVczBYZDJIeDVEUHVRU1UxRnVsb0VBT1h1RmJzaTNjMTA5OUVjb2JMc3hjNnd6UWxTbFNDQjNjQlNsNGtIQmJJMlJpWG0tZVFsMU5PWmVGN19XaHUwWDUtM0NTVzNLV2RNZWx1dHlrQzR3?oc=5","date":"2025-06-19","type":"pipeline","source":"PR Newswire","summary":"Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society's 67th Annual Scientific Meeting - PR Newswire","headline":"Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society's 67th Annual ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPTzVVaGJGaWVMZHFzNzZ5YzdaMTRrbENvYjFpR1NraU80OEZpd1pfVml5NVZfS3pFNHNtNldXVWNyTjl6NDlwS0QzRHdkSUdDVnhqeHRxWjBkNjZVeTNlVE9EWmlXdXJyZzZCSTdQb0lxLVBmWlNRRmZGVWR4azBvcnR0YXBVbzNsR0lvQTZ5WUxzd1dLc1d0ZnpteE84N01UWG94M1pNOXNIemc?oc=5","date":"2025-05-01","type":"regulatory","source":"Contract Pharma","summary":"Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi - Contract Pharma","headline":"Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNNWdrSlVaSHBieU5PbU5kM0NJNzJXQjd4Q19VajBFdldET1NDY1ZQS0xYakVxZTk1YzEtUDV6QkM0QjVoUDRuSW9qcHZNSHlfV1ptY2JRWmY4ZUF0TmdpM1M3MTFGamxaaEY1TktEU09RcEFJQmoxaHpweTNJMkdzSTNOTkdXSUdRR1Rka2hoeGluQkZndUhpNHR1aW8xWkRsV3J3dEszcHBZSG5FcW5sYUd4aVU5NGRHV0xtbDhaQ245ZVJNenNkQktFVl9pNElqSUpmVkw0ZmFQejZJZEJuUWtXZXJkMm9pNGhDd2FKMTJUcjIzMkw5SXdyM0YwX3RWbUllM3J3?oc=5","date":"2025-04-30","type":"pipeline","source":"IANS","summary":"Indo-Asian News Service - IANS","headline":"Indo-Asian News Service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPbG4xUmxXMXppeDR4OXd6Q0hhUzc2empkbGt3OVZ6bnZKRnVQb1RWSlZIOHBndjV5ellkSkpkV3Z3dmR0REc0UU9RbW1UV0N5eGpXb2NHYXNCTDNBSTVBc3EzdkYza0RiQmszN1h4TndUaU85U21oRFBtdk15cUlHRHhRbjI2N2dfWUNqSXZ0andSZw?oc=5","date":"2024-08-16","type":"deal","source":"BioPharma APAC","summary":"SNBL to Acquire Satsuma Pharmaceuticals - BioPharma APAC","headline":"SNBL to Acquire Satsuma Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOZmFQZ0xyS3h6dnNNbXJXak9BbnN2WW9kU1M0MHFZM1ZlSXRfZzU5MlVoMlNic3RqMW5STzBKR0ZDbm81OGRTUDA2b2RDMHN1T3BTYk0yX3JDQjBHbVE1YWRxQU5xanlIbjZoQ2dTUVF5VDNfdklKVmctZDhHcXhlU2NlZ0M?oc=5","date":"2024-01-19","type":"regulatory","source":"pharmaphorum","summary":"FDA turns down Satsuma’s nasal migraine treatment - pharmaphorum","headline":"FDA turns down Satsuma’s nasal migraine treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOYzhXSGtjWVVsQzVSV0FaeUpVaDBqcUFtZm1ibGhqOXBRRVh6UDVSNWxuV2VaNGl2TkdnVm1aeVNQRmRuSmdWOWNvQlg3NmtYY1VFSzZvLW8wRDFCM3VJeC1IMGpIVlppMUx4VU1PZ3VqaFJ3aElfdms5Yi1DYmNLa3V3Qm5POHlWSDdMSTVCcjFCTXd0WUh6NDZzLUhzZVF3LXJCRk5tMGRiWWQ2RUFSQ0c3OTRWX2VZMGFlU1lsMmpsTUhZV3FGWmpHX1JtQQ?oc=5","date":"2024-01-18","type":"regulatory","source":"reuters.com","summary":"US FDA declines to approve Shin Nippon Biomedical's migraine drug - reuters.com","headline":"US FDA declines to approve Shin Nippon Biomedical's migraine drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOTWdCNEJqemlTWXJrZjktYVN6UWtjTWJkUFhVOTBkbFVIYTBaTjRHaDFMeUxKRi1hZzJsdV93T21seF9Eei1sZjItZDVneTNpYkdFNjFlNmdidjdCUkhhWnhYTGhraGRwWk15S3B4WXF0SHF3U0lOTU8zdF83MDEwVk92ZzBlc2c?oc=5","date":"2023-04-17","type":"deal","source":"Pharmaceutical Technology","summary":"SNBL agrees to buy Satsuma Pharmaceuticals - Pharmaceutical Technology","headline":"SNBL agrees to buy Satsuma Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOWGtjUzhnbFRCYnlCSzFPczREd21CdmQ2VHBQWGxkbFlMd1l5dERIemt1X24tSWdVWWFMOUZRa2FKX1BYMmRtYm94aUJLZVV3REYtZndmRm9XSEZwWlpLZWlaVXJ3Nk9KQmNHV2ZhOFVsR0F1MnpUTV9WRDdPbHRQdUxqQ1JwWm8xejJPWXBhYlpEUktDOHRCYUNSSXpoX2Q2SWNaU1FMbDl1YWFiZkFoVg?oc=5","date":"2023-04-16","type":"deal","source":"GlobeNewswire","summary":"SNBL to Acquire Satsuma Pharmaceuticals - GlobeNewswire","headline":"SNBL to Acquire Satsuma Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5HQ29DM1lPYmhKMGdVNDRsaXc0VHBvclRINGRNdXlhbUVPcDJfeFV2REx2WDFsZDJFM3NxNDRSd3pRbU42ZjBWbWw3ZmxIUWZfd0hpVW8wNGZDT2ttcnVTbmZRTlNpM3JoWnZQQThNTHpuaGI2MVE?oc=5","date":"2020-12-24","type":"pipeline","source":"The Worldfolio","summary":"SNBL’s “Nose-to-Brain” technology for fast drug absorption - The Worldfolio","headline":"SNBL’s “Nose-to-Brain” technology for fast drug absorption","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNOG9veVVIQ2V5SmJWNU41RXMxRmFmekdST21ubU5zemF5YlZyWTRXS2h3d1RicHpNWkV4cjRLNWNZeTBwOWZxN1BMSG4zdk5xTVVMbjhSZWtZeElDQlZKVHVhZjZzOTF0X3N1ODdjZkdNZHZKdlJHVDJwb1MwMGdrcGtPd1NvWG1mdkE?oc=5","date":"2017-03-01","type":"deal","source":"drugdiscoverytrends.com","summary":"Pharmaron Acquires Majority Stake in SNBL CPC - drugdiscoverytrends.com","headline":"Pharmaron Acquires Majority Stake in SNBL CPC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFA4ajlfaFRQeWVxN1c4VW9mbi0yT2o1SDhGQmtqWngxZy16MDhYRVRUS05sTE4tV0FMNUpPZ0RLMU1WSU9KTG44QXhsemotclpOX2VhU2FYWlJINkQzWXJtOUlKRC1DeWVlYUJ5SVowTTdTanNuaHFULUhqdzA?oc=5","date":"2012-11-14","type":"regulatory","source":"Contract Pharma","summary":"FDA Closes Out SNBL Issues - Contract Pharma","headline":"FDA Closes Out SNBL Issues","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}